Edinburgh Molecular Imaging Announce Bowel Cancer UK and Beating Bowel Cancer as Charity Partner

Bowel Cancer UK and Beating Bowel Cancer announced as Edinburgh Molecular (EM) Imaging’s Charity partner.

21 March 2018 – EM Imaging, based in Edinburgh, is partnering with Bowel Cancer UK and Beating Bowel Cancer to raise funds for the charity and increase awareness of Scotland’s second biggest cancer killer. The clinical phase biotechnology company focuses on enabling image guided therapy.

The company’s molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue.

Emma McGeever, Scotland Fundraising Manager at Bowel Cancer UK and Beating Bowel Cancer, said: “We are absolutely delighted to be chosen as EM Imaging’s Charity partner. Bowel cancer is Scotland’s third most common cancer and without the amazing support from organisations like EM Imaging we couldn’t continue to fund the highest quality research and essential information and support services that will save lives from bowel cancer.”

John Jeans, Chairman of the Board at EM Imaging Ltd., said: “It is with great pleasure that EM Imaging will be working with Bowel Cancer UK and Beating Bowel Cancer to help raise funds for, and awareness of, this devastating disease. We are already looking forward to our first fund raising events this year with EM Imaging employees participating in #RowAMarathon in June and the Edinburgh Half Marathon. EM Imaging’s mission to help improve patient outcomes in bowel cancer can only be helped by working with such inspiring partners.”


Click here to see the original press release.